Rheumatology

Systemic lupus erythematosus (SLE), a complex, chronic autoimmune disease, affects around 3.41 million people globally. Two experts…

In our latest issue of EMJ Rheumatology, you can explore exclusive interviews with experts in the field, insightful peer-reviewed articles…

Spotlighting a GSK-sponsored Innovation Theatre session that took place on the 14th November 2023 at the American College of…

We are excited to announce the latest issue of EMJ Rheumatology, including a review of the European Alliance of Associations for Rheumatology (EULAR) 2023 Congress, highlighting key sessions from the event.

Osteoarthritis is the most common form of long-term musculoskeletal disease, and is increasing in prevalence as societies become older. One of the key factors of living well with a disease that spans decades of a patient’s life is to diagnose the condition earlier, long before the disease limits function significantly, or causes disability.

Welcome to our latest issue of EMJ Rheumatology, sharing innovative case studies and research on the latest medical developments in the field. Featured articles include a review of the current understanding of metabolic syndrome, and an article summarising the functions and regulations of Type I interferons in the pathogenesis of Sjögren’s syndrome. The eJournal issue also reviews the fantastic EULAR 2022 Congress, and highlights key takeaway points.

Axial spondyloarthritis (AxS) and psoriatic arthritis (PsA) are two types of chronic inflammatory disease presented with an array of unmet needs regarding their diagnosis and management. Presenting symptoms such as axial skeleton pain, enthesitis, and arthritis, patients with AxS and PsA commonly experience diagnostic delay, which hinders disease evaluation…

Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) refers to a group of rare autoimmune inflammatory…